Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier fo...(ing release contains forward-looking sta...),Health

Date:7/30/2008

ing release contains forward-looking statements that can be identified by terminology such as "launch," "may," "continues to seek," "improving," or similar expressions, or by express or implied discussions regarding potential future results of Patient Assistance Now or regarding potential impact on future revenues from Patient Assistance Now. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that any Novartis prescription medicine will be provided discounted or free as a result of Patient Assistance Now. Nor can there be any guarantee that any information provided through Patient Assistance Now will impact an individual's health or disease or condition management. Neither can there be any guarantee that Patient Assistance Now will have any particular impact on Novartis revenues. In particular, management's expectations regarding Patient Assistance Now could be affected by, among other things, unexpected changes to program eligibility or qualification factors; unexpected changes to insurance or prescription drug coverage plans; unexpected regulatory actions or delays or government regulation generally; competition in general; government, industry and general public pricing pressures; the company's ability to obtain or maintain patent or other propriety intellectual property protection, and other risks and factors referred to in Novartis AG's current form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
2. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
3. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
4. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
5. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
6. Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
7. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
8. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
9. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
10. Dr. Web Makes Many Americans Question Trusted Health Providers
11. BCBSNC Makes Electronic Prescribing Available Statewide